b. waistline."
c. breast."
d. abdomen."
A)
periodically fire just to test for lead placement and battery life.
B)
respond to ventricular tachyarrhythmia by delivering a shock within 10 to 20 seconds of its onset.
C)
use radiofrequency energy to deliver an electrical shock through the site where the lethal rhythm originates.
D)
remove scar tissue and aneurysm during placement of electrodes and then will shock if paradoxical ventricular movement is located.
Ans:
B
Feedback:
AICD successfully treats individuals with life-threatening ventricular tachyarrhythmias by use of intrathoracic electrical countershock. It senses and detects ventricular dysrhythmias. It responds by delivering an electrical shock between intrathoracic electrodes within 10 to 20 seconds of its onset. It does not periodically fire to test lead placement. It does not utilize radiofrequency energy (this is used in ablations). The procedure does not remove scar tissue or aneurysms. This is a ventriculotomy.
A newly diagnosed type 2 diabetic patient is started on a new drug that comes from incretin hormones. Glucagon-like peptide 1 (GLP1) is used because of which effect?
a. It has the least allergic effect. b. It is easy to administer. c. It inhibits glucagon secretion. d. It slows islet growth.
Before administering a prescribed bronchodilator to a client experiencing acute breathing distress, which of the following would be appropriate for the nurse to assess? Select all that apply
A) Blood pressure B) Blood glucose C) Pulse D) Lung sounds E) Respiratory rate
The nurse is providing patient education about the application of transdermal estrogen. Which statement made by the patient best demonstrates understanding of the application of this medication? "I should apply this medication to my
Blood pressure depends on the
A. rate of the heartbeat. B. force of the heartbeat. C. respiratory rate. D. amount of oxygen in the blood.